Versant Capital Management, Inc - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 54 filers reported holding APTEVO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$041
-33.9%
0.00%
Q4 2018$062
-10.1%
0.00%
Q3 2018$069
-24.2%
0.00%
Q2 2018$0910.0%0.00%
Q1 2018$0910.0%0.00%
Q4 2017$0910.0%0.00%
Q3 2017$0910.0%0.00%
Q2 2017$0910.0%0.00%
Q1 2017$091
-25.4%
0.00%
Q4 2016$0122
-8.3%
0.00%
Q3 2016$01330.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,413,421$2,008,0001.95%
Worth Venture Partners, LLC 375,669$221,0000.13%
Park West Asset Management LLC 1,000,000$588,0000.03%
ALGERT GLOBAL LLC 74,906$44,0000.02%
Sessa Capital IM, L.P. 180,149$106,0000.01%
ATLAS CAPITAL ADVISORS LLC 49,045$28,858,0000.01%
Point72 Asset Management, L.P. 2,450,000$1,442,0000.01%
Alyeska Investment Group, L.P. 750,000$441,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 78,000$46,0000.00%
A.R.T. Advisors, LLC 69,934$41,0000.00%
View complete list of APTEVO THERAPEUTICS INC shareholders